Rodney Guiseppi, MD
Retina Specialist · Galveston, TXNPI 1801393855
Payments from drug & device makers
What this record shows
Bausch & Lomb Americas Inc. accounts for 72.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $2,057 and has fallen 98.7% since, to $26 in 2025.
Across 27 payments — averaging $104.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$2K
- Alcon$171
- Carl Zeiss Meditec USA, Inc.$138
- Amgen$123
- Regeneron Healthcare Solutions, Inc.$122
- Tarsus Pharmaceuticals, Inc.$105
- plus $115 from 2 others
What the payments were for
- Travel & lodging$1,54154%
- Food & beverage$1,29246%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 18 | $2,057 |
| Alcon | 2 | $171 |
| Carl Zeiss Meditec USA, Inc. | 1 | $138 |
| Amgen | 1 | $123 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Tarsus Pharmaceuticals, Inc. | 2 | $105 |
| Alimera Sciences, Inc. | 1 | $89 |
| Genentech USA, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS$1,500
- OPHTHALMIC INSTRUMENTS$1,500
- Clareon$127
- UPLIZNA$123
- EYLEA HD$122
How this compares
$2,833 in reported general payments places this provider in the 55th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 62 | $1,720 |
| MoxifloxacinMoxifloxacin Hcl | 35 | $688 |
| Ketorolac Tromethamine | 13 | $280 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Galveston
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Judy KimDallas$256K
- Emmanuel ChangBellaire$254K
- Ting Fang SuarezBellaire$156K
- Hemang PandyaPlano$153K
- Margaret RunnerSouthlake$71K
- Moises ChicaSan Antonio$43K
- Garvin DavisHouston$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.